Legal Advocacy, Drug Policy and Psychoactive Plants

The authors emphasize the disconnect between traditional plant practices and the modern drug control system, which fails to account for cultural, historical, and ritual contexts. The global drug control regime, established in the early 20th century, did not originally consider psychoactive plants like ayahuasca, mescaline, or psilocybin mushrooms. As a result, these plants exist in a legal limbo in many countries, where their use for ritual or therapeutic purposes is often misunderstood and criminalized. The chapter notes how international drug control bodies, such as the INCB, do not recognize the legal status of these plants, leaving their regulation to be interpreted differently by individual countries. This has led to the criminalization of practices that were previously culturally embedded and understood as sacred.

Furthermore, the study critiques the reductionist approach of modern drug policy, which tends to categorize psychoactive plants solely by their active chemical components, disregarding their cultural significance. For example, ayahuasca is often reduced to its DMT content, and San Pedro cactus to mescaline, neglecting the rich spiritual and ritual contexts in which they are used. Despite these challenges, there have been legal successes, such as religious exemptions for ayahuasca use in certain countries. The authors conclude by advocating for the continued evolution of drug policies that integrate cultural, scientific, and human rights considerations. They call for greater support for Indigenous rights and the legal recognition of traditional plant-based practices to ensure their safe and legitimate use in modern societies.